Editors' Note

Editors' Note: In "Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis," authors Filli et al. showed that prolonged-release fampridine improved walking speed, endurance, and self-perceived ambulatory function in patients with multiple sclerosis (MS). Furthermore, patients showed additional drug responsiveness with long-term treatment.

http://www.neurology.org/cgi/content/short/89/11/1199?rss=1

Source: Neurology - September 11, 2017 Category: Neurology Authors: Karam, C., Griggs, R. C. Tags: WRITECLICK & amp;reg; EDITOR ' S CHOICE Source Type: research

More News: Brain | Multiple Sclerosis | Neurology